Deprescribing in dermatology: a systematic review of current dermatological guidelines.
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
23
02
2018
accepted:
10
08
2018
pubmed:
14
2
2019
medline:
25
2
2020
entrez:
14
2
2019
Statut:
ppublish
Résumé
The term "deprescribing" refers to the systematic process of identifying, tapering, and discontinuing individually ineffective and/or potentially harmful drugs. Considering various aspects, the present review addresses the concept of "deprescribing" in the context of recommendations for use of systemic drugs contained in current dermatological guidelines. Overall, 16 sets of guidelines developed under the auspices of the German Society of Dermatology (DDG) were reviewed. Our analysis shows that many guidelines contain no or insufficient information in terms of deprescribing systemic drugs. We therefore propose that future guidelines and guideline updates should include standardized recommendations for discontinuation or dose adjustment of systemic therapies.
Substances chimiques
Dermatologic Agents
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
261-265Informations de copyright
© 2019 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.